Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future

The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti-tumor immune response in a wide range of malignancies, most notably with early evidence of efficacy in hematologic maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamb, Margaret G., Rangarajan, Hemalatha G., Tullius, Brian P., Lee, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992329/
https://www.ncbi.nlm.nih.gov/pubmed/33766099
http://dx.doi.org/10.1186/s13287-021-02277-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992329/
https://www.ncbi.nlm.nih.gov/pubmed/33766099
http://dx.doi.org/10.1186/s13287-021-02277-x

Ejemplares similares